COVID Ethics has been warning about the risk of blood clots, cerebral vein thrombosis, and sudden death from gene-based COVID-19 “vaccines.”
The signees noted numerous important questions, including proof that gene-based vaccinations do not enter the bloodstream and spread throughout the body, or that vaccines do not become stuck in circulation and taken up by endothelial cells.
They warned that, absent such proof, “peptides produced from the spike protein will be presented via the MHCI route at the luminal surface of the cells after translation of the vaccines’ nucleic acids,” and that many healthy people have CD8-lymphocytes that detect these peptides —either as a result of earlier COVID-19 infection or as a result of cross-reaction with other coronaviruses that cause the common cold.
“Unless there is proof to the contrary,” they wrote, “we must assume that these lymphocytes will mount an attack on the corresponding cells.”
They warned that if lymphocytes target cells, “endothelial damage with sequential prompting of blood coagulation via platelet activation will occur,” as well as “myriad ischemic lesions throughout the body, including the brain, spinal cord, and heart.” “Profound bleedings and hemorrhagic stroke” ensued.
Thrombocytopenia After Vaccination
The SARS-CoV-2 spike protein interacts to the ACE2 receptor on platelets, according to studies. Disseminated intravascular coagulation (DIC) is a pathological overstimulation of your coagulation system that can result in aberrant and life-threatening blood clotting, as well as thrombocytopenia (low platelet count) and bleeding.
Platelets are specialized cells that prevent blood from clotting. As doctor says, your coagulation system becomes overworked as a result of the accumulation of blood clots throughout your vascular system, resulting in bleeding (hemorrhaging). Thrombocytopenia, or a low platelet count, has been described in both severe COVID-19 cases and vaccinated people, suggesting that the spike protein could be a factor.
The signees also want proof that “an actual emergency existed at the time of the EMA granting Conditional Marketing Authorization to the manufacturers of all three vaccines, to justify their approval for use in humans,” given that most hospitals in most countries were no longer at capacity at the time the authorizations were granted.
“There are serious concerns, including but not confined to those outlined above, that the approval of the COVID-19 vaccines by the EMA was premature and reckless, and that the administration of the vaccines constituted and still does constitute ‘human experimentation,’ which was and still is in violation of the Nuremberg Code,” the letter states.
